BioSpace News Archive

Press Releases

Merck’s LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia

July 16, 2026
·
11 min read
Press Releases

Compvide™ Announces Strategic Collaboration with OpZira™ to Accelerate Growth and Advance the CIMED™ Platform

July 16, 2026
·
2 min read
Press Releases

OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme

July 16, 2026
·
4 min read
Press Releases

Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

July 16, 2026
·
1 min read
Press Releases

Remix Therapeutics to Present at AACR Drug Discovery and Development Conference

July 16, 2026
·
3 min read
Press Releases

Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025

July 16, 2026
·
5 min read
Press Releases

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - July 16, 2026

July 16, 2026
·
2 min read
Press Releases

uBriGene Launches uVivo Lentiviral Vector Platform to Accelerate the Development of Next-Generation In Vivo CAR-T Therapies

July 16, 2026
·
3 min read
Press Releases

Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors

July 16, 2026
·
4 min read
Press Releases

Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

July 16, 2026
·
13 min read